Biogen reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Biogen using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-30 | $4.08 | $3.79 | 7.65 % |
Jun 2024 | 2024-08-01 | $5.28 | $4.02 | 31.3 % |
Mar 2024 | 2024-04-24 | $3.67 | $3.44 | 6.69 % |
Dec 2023 | 2024-02-13 | $2.95 | $3.18 | -7.23 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-30 | $2.47B | $2.43B | 1.48 % |
Jun 2024 | 2024-08-01 | $2.47B | $2.38B | 3.57 % |
Mar 2024 | 2024-04-24 | $2.29B | $2.31B | -0.82 % |
Dec 2023 | 2024-02-13 | $2.39B | $2.47B | -3.20 % |
Biogen (BIIB) is scheduled to report earnings on February 11, 2025. The last reported earnings were for reported on October 30, 2024 for Q3.
The Actual EPS was $4.08, which beat the estimate of $3.79.
The Actual Revenue was $2.5B, which beat the estimate of $2.4B.
Browse earnings estimates, EPS, and revenue on all stocks.